Insider Stock Trading History of Keller Deborah L


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Keller Deborah L since year 2005. The trader's CIK number is 1352992. At the time of this reporting, Keller Deborah L is the CEO, Covance Drug Development of Laboratory Corp Of America Holdings . (stock ticker symbol LH). See this page for all insider trading activities at Laboratory Corp Of America Holdings .

Note that in the past Keller Deborah L also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Keller Deborah L since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-03-11 LH Laboratory Corp Of America Holdings Option Ex 12,930 .00 0
2014-12-05 CVD Covance Inc Option Ex 22,000 67.86 1,492,876
2014-12-05 CVD Covance Inc Sale 17,770 103.13 1,832,637
2014-02-07 CVD Covance Inc Option Ex 11,100 39.80 441,779
2014-02-07 CVD Covance Inc Sale 14,165 98.14 1,390,153
2013-08-21 CVD Covance Inc Option Ex 14,700 53.72 789,639
2013-08-21 CVD Covance Inc Sale 15,900 83.12 1,321,608
2012-11-16 CVD Covance Inc Sale 2,962 54.55 161,577
2011-03-31 CVD Covance Inc Option Ex 3,700 26.32 97,384
2011-03-31 CVD Covance Inc Sale 11,318 54.77 619,886
2008-08-28 CVD Covance Inc Option Ex 3,804 43.70 166,234
2008-08-28 CVD Covance Inc Sale 3,804 95.00 361,380
2007-09-11 CVD Covance Inc Sale 3,000 75.35 226,040
2007-09-11 CVD Covance Inc Option Ex 3,000 22.95 68,850

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Keller Deborah L (CEO, Covance Drug Development of Laboratory Corp Of America Holdings at the time of this reporting) see the Securities and Exchange Commission (SEC) website.